On August 30, 2019 Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported that it is scheduled to participate in the following upcoming events (Press release, Arrowhead Pharmaceuticals, AUG 30, 2019, View Source [SID1234539173]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Baird’s 2019 Global Healthcare Conference – New York, September 4-5, 2019
September 4, 9:40 a.m. EDT –Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will deliver a corporate presentation
Citi’s 14th Annual Biotech Conference– Boston, September 5, 2019
Global Summit on Cardiology and Heart Diseases – Dubai, UAE, September 16-17, 2019
September 16, 11:00 a.m. GST –Bruce Given, M.D., Arrowhead’s chief operating officer and head of R&D, will deliver a keynote presentation titled, "Treating hypertriglyceridemic states with RNA interference – emergence of an exciting new modality to treat cardiovascular diseases"
A copy of the presentation materials and webcast links, if the presentation is being webcast, may be accessed on the Events and Presentations page under the Investors section of the Arrowhead website.